Just musing on the shape of a licensing deal with Vet...

Just musing on the shape of a licensing deal with Vet Major.

Would it only cover the treatment of B Cell Lymphoma in canines or would VM be free to use licensed MPL for other veterinary indications as they see fit?

Would PAA be fully disposing of all future veterinary uses? I feel this aspect of our drug has not been substantially explored. I'm unsure if the patents we hold cover ALL veterinary indications.

For example, could MPL have anti-parasitic properties for canines (as it does in sheep). Could MPL have off-target properties in other common pet diseases? Could VM sub-license MPL as a trace additive to a pet food manufacturer claiming it may have prophylactic benefits for the animal? Pet food additives only have to be GRS (Generally Regarded as Safe) and do not require FDA approval.

If any of these scenario's are somewhat realistic, surely it would drive the value proposition of MPL upwards.

An upfront deal and royalties would be most welcome, but I'd hate to see it going for a song if VM can exploit the product in future.

I would appreciate anyone's thoughts on this.